Authors: Dai, Y Masterman, T Huang, WX Sandberg-Wollheim, M Laaksonen, M Harbo, HF Oturai, A Ryder, LP Soelberg-Sorensen, P Svejgaard, A Hillert, J

Citation: Y. Dai et al., Analysis of an interferon-gamma gene dinucleotide-repeat polymorphism in Nordic multiple sclerosis patients, MULT SCLER, 7(3), 2001, pp. 157-163

Authors: Isojarvi, JIT Tauboll, E Pakarinen, AK van Parys, J Rattya, J Harbo, HF Dale, PO Fauser, BCJM Gjerstad, L Koivunen, R Knip, M Tapanainen, JS

Citation: Jit. Isojarvi et al., Altered ovarian function and cardiovascular risk factors in valproate-treated women, AM J MED, 111(4), 2001, pp. 290-296

Authors: Celius, EG Harbo, HF Egeland, T Vartdal, F Vandvik, B Spurkiand, A

Citation: Eg. Celius et al., Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype inmultiple sclerosis, J NEUR SCI, 178(2), 2000, pp. 132-135

Authors: Tauboll, E Isojarvi, JIT Harbo, HF Pakarinen, AJ Gjerstad, L

Citation: E. Tauboll et al., Long-term valproate treatment induces changes in ovarian morphology and serum sex steroid hormone levels in female Wistar rats, SEIZURE-E J, 8(8), 1999, pp. 490-493

Authors: Harbo, HF Celius, EG Vartdal, F Spurkland, A

Citation: Hf. Harbo et al., CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis, TISSUE ANTI, 53(1), 1999, pp. 106-110